Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO495 | Daemonorops draco | Species | Arecaceae | Eukaryota | TCM_Taiwan* | |||
NPO29581 | Dalbergiae odoriferae lignum | NA | NA | NA | TCMSP* | |||
NPO10494 | Alpinia katsumadai | Species | Staphylinidae | Eukaryota | TM-MC* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT165 | Cell Line | HeLa | Homo sapiens | ED | = | 3.1 | ug/ml | 2362275 |
NPT3803 | Individual Protein | Tumor necrosis factor receptor R1 | Homo sapiens | IC50 | = | 23000 | nM | 15006393 |
NPT605 | Organism | Homo sapiens | Homo sapiens | IC50 | = | 6280 | nM | 8496911 |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 20000 | nM | 9822551 |
NPT168 | Cell Line | P388 | Mus musculus | IC50 | = | 9630 | nM | 9544201 |
NPT137 | Cell Line | L1210 | Mus musculus | IC50 | = | 41400 | nM | 9544201 |
NPT605 | Organism | Homo sapiens | Homo sapiens | IC50 | = | 12700 | nM | 9544201 |
NPT605 | Organism | Homo sapiens | Homo sapiens | IC50 | = | 12500 | nM | 9544201 |
NPT3804 | Cell Line | Human Tumor Cell lines | IC50 | = | 8320 | nM | 9544201 | |
NPT440 | Individual Protein | Quinone oxidoreductase | Mus musculus | CD | = | 0.031 | nM | 9857096 |
NPT2 | Others | Unspecified | Inhibition | = | 92.8 | % | 12467629 | |
NPT2 | Others | Unspecified | Inhibition | = | 94.4 | % | 12467629 | |
NPT3805 | Individual Protein | Cyclooxygenase-1 | Mus musculus | IC50 | = | 22100 | nM | 15109651 |
NPT581 | Individual Protein | Cyclooxygenase-2 | Mus musculus | IC50 | = | 11200 | nM | 15109651 |
NPT3806 | Individual Protein | Arachidonate 5-lipoxygenase | Mus musculus | IC50 | = | 12200 | nM | 15109651 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 6.7 | ug/ml | 16153842 |
NPT299 | Individual Protein | Androgen Receptor | Rattus norvegicus | IC50 | = | 64565.42 | nM | 16134935 |
NPT20 | Organism | Candida albicans | Candida albicans | MIC | = | 62.5 | ug/ml | 17007965 |
NPT20 | Organism | Candida albicans | Candida albicans | MIC | = | 125 | ug/ml | 17007965 |
NPT20 | Organism | Candida albicans | Candida albicans | IZ | = | 30 | mm | 17007965 |
NPT384 | Cell Line | TK-10 | Homo sapiens | Activity | = | 2 | % | 17383189 |
NPT83 | Cell Line | MCF7 | Homo sapiens | Activity | = | 19 | % | 17383189 |
NPT139 | Cell Line | HT-29 | Homo sapiens | Activity | = | 5 | % | 17383189 |
NPT384 | Cell Line | TK-10 | Homo sapiens | IC50 | = | 42000 | nM | 17383189 |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 63000 | nM | 17383189 |
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | = | 70000 | nM | 17383189 |
NPT88 | Organism | Mycobacterium tuberculosis | Mycobacterium tuberculosis | Activity | = | 41.93 | % | 17276682 |
NPT88 | Organism | Mycobacterium tuberculosis | Mycobacterium tuberculosis | Activity | = | 50.64 | % | 17276682 |
NPT1208 | Organism | Leishmania braziliensis | Leishmania braziliensis | IC50 | = | 13700 | nM | 17112640 |
NPT2 | Others | Unspecified | IC50 | > | 50000 | nM | 18032041 | |
NPT2 | Others | Unspecified | Inhibition | = | 24.2 | % | 18032041 | |
NPT1308 | Tissue | Blood | Homo sapiens | IC50 | = | 162560 | nM | 18053717 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | IZ | = | 29 | mm | 18584918 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 125 | ug/ml | 18584918 |
NPT312 | Organism | Saccharomyces cerevisiae | Saccharomyces cerevisiae | MIC | > | 40 | ug/ml | 18280009 |
NPT3807 | Organism | Pichia angusta | Pichia angusta | MIC | = | 30 | ug/ml | 18280009 |
NPT3807 | Organism | Pichia angusta | Pichia angusta | MIC | < | 20 | ug/ml | 18280009 |
NPT3807 | Organism | Pichia angusta | Pichia angusta | MIC | = | 25 | ug/ml | 18280009 |
NPT3807 | Organism | Pichia angusta | Pichia angusta | MIC | = | 20 | ug/ml | 18280009 |
NPT3807 | Organism | Pichia angusta | Pichia angusta | MIC | > | 40 | ug/ml | 18280009 |
NPT3808 | Organism | Kluyveromyces lactis | Kluyveromyces lactis | MIC | < | 20 | ug/ml | 18280009 |
NPT3808 | Organism | Kluyveromyces lactis | Kluyveromyces lactis | MIC | = | 25 | ug/ml | 18280009 |
NPT35 | Others | n.a. | Activity | = | 7.1 | ug/ml | 18280009 | |
NPT582 | Individual Protein | Monoamine oxidase B | Homo sapiens | IC50 | = | 1410 | nM | 19378991 |
NPT2 | Others | Unspecified | Ratio IC50 | > | 14 | 19378991 | ||
NPT992 | Organism | Entamoeba histolytica | Entamoeba histolytica | IC50 | = | 1700 | nM | 18378360 |
NPT2 | Others | Unspecified | Ratio IC50 | > | 29.41 | 18378360 | ||
NPT2 | Others | Unspecified | IC50 | = | 10000 | nM | 19507860 | |
NPT2 | Others | Unspecified | IC50 | > | 20000 | nM | 19883086 | |
NPT111 | Cell Line | K562 | Homo sapiens | IC50 | = | 3800 | nM | 19837593 |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 22387.2 | nM | PubChem BioAssay data set |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 4466.8 | nM | PubChem BioAssay data set |
NPT2741 | Individual Protein | Pyruvate kinase | Leishmania mexicana | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT484 | Individual Protein | Luciferin 4-monooxygenase | Photinus pyralis | Potency | = | 10000 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 14125.4 | nM | PubChem BioAssay data set |
NPT3 | Individual Protein | Thioredoxin glutathione reductase | Schistosoma mansoni | Potency | = | 28183.8 | nM | PubChem BioAssay data set |
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 19952.6 | nM | PubChem BioAssay data set |
NPT54 | Individual Protein | Nonstructural protein 1 | Influenza A virus | Potency | = | 2511.9 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 35481.3 | nM | PubChem BioAssay data set | |
NPT2561 | Individual Protein | Triosephosphate isomerase, glycosomal | Trypanosoma cruzi | Inhibition | = | 33 | % | 20889239 |
NPT2 | Others | Unspecified | Ratio | > | 4 | 20889239 | ||
NPT2 | Others | Unspecified | IC50 | > | 20000 | nM | 21112783 | |
NPT2 | Others | Unspecified | IC50 | = | 7000000 | nM | 21349727 | |
NPT530 | Organism | Caenorhabditis elegans | Caenorhabditis elegans | Activity | = | 100 | % | 21349727 |
NPT530 | Organism | Caenorhabditis elegans | Caenorhabditis elegans | Inhibition | = | 0 | % | 21349727 |
NPT532 | Individual Protein | Lysine-specific demethylase 4A | Homo sapiens | Potency | 79432.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | = | 4245 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 1258.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | = | 4194 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 25929 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 14581 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | FC | = | 0.7 | 21539383 | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | FC | = | 1.8 | 21539383 | |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 17782.8 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 10417.9 | nM | PubChem BioAssay data set | |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 63095.7 | nM | PubChem BioAssay data set | |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 22387.2 | nM | PubChem BioAssay data set | |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | 100000 | nM | PubChem BioAssay data set | |
NPT698 | Individual Protein | Regulator of G-protein signaling 4 | Homo sapiens | Potency | 70794.6 | nM | PubChem BioAssay data set | |
NPT9 | Individual Protein | DNA polymerase eta | Homo sapiens | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 7943.3 | nM | PubChem BioAssay data set | ||
NPT65 | Cell Line | HepG2 | Homo sapiens | Potency | 17782.8 | nM | PubChem BioAssay data set | |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT484 | Individual Protein | Luciferin 4-monooxygenase | Photinus pyralis | Potency | 2393.4 | nM | PubChem BioAssay data set | |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 4073.8 | nM | PubChem BioAssay data set | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 4841.72 | nM | PubChem BioAssay data set | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 937.56 | nM | PubChem BioAssay data set | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 6576.58 | nM | PubChem BioAssay data set | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 3341.95 | nM | PubChem BioAssay data set | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 3784.43 | nM | PubChem BioAssay data set | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 4852.89 | nM | PubChem BioAssay data set | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 1896.71 | nM | PubChem BioAssay data set | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 15848.9 | nM | PubChem BioAssay data set | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 2009.09 | nM | PubChem BioAssay data set | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 2697.74 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 29934.9 | nM | PubChem BioAssay data set | ||
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT888 | Individual Protein | 78 kDa glucose-regulated protein | Homo sapiens | Potency | 44668.4 | nM | PubChem BioAssay data set | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 9549.93 | nM | PubChem BioAssay data set | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 25929 | nM | PubChem BioAssay data set | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 8128.31 | nM | PubChem BioAssay data set | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 11220.2 | nM | PubChem BioAssay data set | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 4830.59 | nM | PubChem BioAssay data set | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 6067.36 | nM | PubChem BioAssay data set | |
NPT2971 | Individual Protein | DNA dC->dU-editing enzyme APOBEC-3F | Homo sapiens | Potency | 6309.6 | nM | PubChem BioAssay data set | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 10000 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Ratio | = | 0.78 | 22310230 | |
NPT83 | Cell Line | MCF7 | Homo sapiens | Activity | = | 103 | % | 22239485 |
NPT83 | Cell Line | MCF7 | Homo sapiens | Activity | = | 115 | % | 22239485 |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | 253 | mg/dl | 22608392 |
NPT1018 | Organism | Trypanosoma brucei | Trypanosoma brucei | IC50 | = | 0.473 | ug/ml | 22360533 |
NPT1460 | Cell Line | L929 | Mus musculus | IC50 | = | 6.92 | ug/ml | 22360533 |
NPT65 | Cell Line | HepG2 | Homo sapiens | Activity | = | 72 | % | 22658085 |
NPT65 | Cell Line | HepG2 | Homo sapiens | Activity | = | 95 | % | 22658085 |
NPT2 | Others | Unspecified | Ratio IC50 | > | 7.78 | 22658085 | ||
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | > | 100000 | nM | 22658085 |
NPT3535 | Organism | Entamoeba histolytica HM-1:IMSS | Entamoeba histolytica HM-1:IMSS | IC50 | = | 12860 | nM | 22658085 |
NPT65 | Cell Line | HepG2 | Homo sapiens | Activity | = | 40 | % | 22658085 |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 6513.1 | nM | PubChem BioAssay data set | |
NPT477 | Individual Protein | DNA dC->dU-editing enzyme APOBEC-3G | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 10000 | nM | PubChem BioAssay data set | ||
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 29092.9 | nM | PubChem BioAssay data set | |
NPT1 | Others | Radical scavenging activity | Activity | = | 18.63 | % | 10.1007/s00044-010-9342-1 | |
NPT2 | Others | Unspecified | Activity | = | 42.43 | % | 10.1007/s00044-010-9342-1 | |
NPT2 | Others | Unspecified | Activity | = | 25.35 | % | 10.1007/s00044-010-9342-1 | |
NPT2 | Others | Unspecified | Activity | = | 32.6 | % | 10.1007/s00044-010-9342-1 | |
NPT1328 | Organism | Culex quinquefasciatus | Culex quinquefasciatus | LC50 | = | 90 | umol/dm3 | 10.1007/s00044-010-9305-6 |
NPT2914 | Organism | Xanthomonas oryzae | Xanthomonas oryzae | IZ | = | 0 | mm | 23229055 |
NPT2915 | Organism | Erwinia chrysanthemi | Erwinia chrysanthemi | IZ | = | 10 | mm | 23229055 |
NPT529 | Organism | Rhizoctonia solani | Rhizoctonia solani | LC50 | = | 2.49 | ug/ml | 23229055 |
NPT722 | Organism | Athelia rolfsii | Athelia rolfsii | LC50 | = | 674 | ug/ml | 23229055 |
NPT1 | Others | Radical scavenging activity | Activity | = | 9.11 | % | 23229055 | |
NPT18 | Organism | Pseudomonas aeruginosa | Pseudomonas aeruginosa | IZ | = | 10 | mm | 23229055 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | IZ | = | 5 | mm | 23229055 |
NPT173 | Organism | Klebsiella pneumoniae | Klebsiella pneumoniae | IZ | = | 0 | mm | 23229055 |
NPT2642 | Organism | Bacillus pumilus | Bacillus pumilus | IZ | = | 0 | mm | 23229055 |
NPT1261 | Organism | Bacillus thuringiensis | Bacillus thuringiensis | IZ | = | 0 | mm | 23229055 |
NPT2 | Others | Unspecified | Potency | 20596.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 14581 | nM | PubChem BioAssay data set | ||
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | 16360.1 | nM | PubChem BioAssay data set | |
NPT165 | Cell Line | HeLa | Homo sapiens | Activity | > | 50000 | % | 23524161 |
NPT165 | Cell Line | HeLa | Homo sapiens | EC50 | > | 50000 | nM | 23524161 |
NPT137 | Cell Line | L1210 | Mus musculus | IC50 | > | 100000 | nM | 23524161 |
NPT927 | Cell Line | PBMC | Homo sapiens | IC50 | = | 27000 | nM | 23524161 |
NPT15 | Cell Line | Jurkat | Homo sapiens | IC50 | = | 17100 | nM | 23524161 |
NPT2 | Others | Unspecified | IC50 | > | 10000 | nM | 23524161 | |
NPT2 | Others | Unspecified | IC50 | = | 43000 | nM | 10.1007/s00044-013-0745-7 | |
NPT183 | Individual Protein | Arachidonate 5-lipoxygenase | Rattus norvegicus | IC50 | = | 43000 | nM | 10.1007/s00044-013-0745-7 |
NPT582 | Individual Protein | Monoamine oxidase B | Homo sapiens | Activity | = | 0.73 | % | 24169316 |
NPT582 | Individual Protein | Monoamine oxidase B | Homo sapiens | IC50 | = | 1412537.54 | nM | 24169316 |
NPT2 | Others | Unspecified | FC | = | 1.9 | 24275249 | ||
NPT2 | Others | Unspecified | EC50 | = | 11000 | nM | 24275249 | |
NPT1021 | Organism | Leishmania infantum | Leishmania infantum | EC95 | = | 69.9 | ug/ml | 24433962 |
NPT1021 | Organism | Leishmania infantum | Leishmania infantum | EC50 | = | 1.3 | ug/ml | 24433962 |
NPT113 | Cell Line | RAW264.7 | Mus musculus | TC50 | = | 30.7 | ug/ml | 24433962 |
NPT1021 | Organism | Leishmania infantum | Leishmania infantum | EC95 | = | 71.1 | ug/ml | 24433962 |
NPT1021 | Organism | Leishmania infantum | Leishmania infantum | EC50 | = | 1.5 | ug/ml | 24433962 |
NPT2 | Others | Unspecified | Inhibition | = | 90.6 | % | 24275249 | |
NPT1045 | Cell Line | U2OS | Homo sapiens | Activity | = | 73.1 | % | 24275249 |
NPT2 | Others | Unspecified | Inhibition | = | 69 | % | 24275249 | |
NPT2 | Others | Unspecified | Inhibition | = | 111.9 | % | 24275249 | |
NPT2 | Others | Unspecified | Inhibition | = | 101.5 | % | 24275249 | |
NPT2 | Others | Unspecified | Inhibition | = | 18.9 | % | 24275249 | |
NPT1021 | Organism | Leishmania infantum | Leishmania infantum | EC95 | = | 79.5 | ug/ml | 24433962 |
NPT1021 | Organism | Leishmania infantum | Leishmania infantum | EC50 | = | 5.1 | ug/ml | 24433962 |
NPT113 | Cell Line | RAW264.7 | Mus musculus | TC50 | = | 28.1 | ug/ml | 24433962 |
NPT1021 | Organism | Leishmania infantum | Leishmania infantum | EC95 | = | 83.5 | ug/ml | 24433962 |
NPT1021 | Organism | Leishmania infantum | Leishmania infantum | EC50 | = | 5.7 | ug/ml | 24433962 |
NPT439 | Individual Protein | Butyrylcholinesterase | Homo sapiens | IC50 | = | 87000 | nM | 24780600 |
NPT616 | Cell Line | MDCK | Canis lupus familiaris | Ratio | = | 3.05 | 25442312 | |
NPT616 | Cell Line | MDCK | Canis lupus familiaris | Ratio | = | 0.33 | 25442312 | |
NPT2 | Others | Unspecified | Ratio | = | 1.33 | 25442312 | ||
NPT2 | Others | Unspecified | Ratio | = | 1.2 | 25442312 | ||
NPT2 | Others | Unspecified | IC50 | = | 43100 | nM | 25091929 | |
NPT2 | Others | Unspecified | IC50 | = | 23900 | nM | 25091929 | |
NPT2 | Others | Unspecified | IC50 | = | 55400 | nM | 25091929 | |
NPT616 | Cell Line | MDCK | Canis lupus familiaris | Activity | = | 4 | % | 25442312 |
NPT2 | Others | Unspecified | Ratio | = | 2.75 | 25442312 | ||
NPT2 | Others | Unspecified | Ratio | = | 0.36 | 25442312 | ||
NPT1 | Others | Radical scavenging activity | IC50 | = | 3139260000 | nM | 25278230 | |
NPT2 | Others | Unspecified | Potency | 39810.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Ratio EC50 | = | 0.7 | 26055530 | ||
NPT634 | Organism | Leishmania amazonensis | Leishmania amazonensis | EC50 | = | 13200 | nM | 26055530 |
NPT1021 | Organism | Leishmania infantum | Leishmania infantum | EC50 | = | 8890 | nM | 26055530 |
NPT2 | Others | Unspecified | Ratio EC50 | = | 1.06 | 26055530 | ||
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | EC50 | = | 102640 | nM | 26055530 |
NPT2 | Others | Unspecified | Ratio EC50 | = | 0.09 | 26055530 | ||
NPT2 | Others | Unspecified | EC50 | = | 9500 | nM | 26055530 | |
NPT2 | Others | Unspecified | IC50 | = | 68.23 | ug/ml | 26188621 | |
NPT329 | Organism | Trichophyton rubrum | Trichophyton rubrum | MIC | = | 1.9 | ug/ml | 26188621 |
NPT329 | Organism | Trichophyton rubrum | Trichophyton rubrum | MIC | = | 7.5 | ug/ml | 26188621 |
NPT2 | Others | Unspecified | IC50 | = | 0.02 | ug/ml | 26188621 | |
NPT2 | Others | Unspecified | IC50 | = | 0.14 | ug/ml | 26188621 | |
NPT3809 | Individual Protein | Pancreatic alpha-amylase | Sus scrofa | Ki | = | 48000 | nM | 26395057 |
NPT2818 | Individual Protein | Dihydrofolate reductase | Homo sapiens | IC50 | > | 100000 | nM | 26994844 |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | = | 12400 | nM | 26994844 |
NPT2 | Others | Unspecified | GI50 | = | 15700 | nM | 26994844 | |
NPT2 | Others | Unspecified | IC50 | = | 10800 | nM | 26994844 | |
NPT2 | Others | Unspecified | IC50 | = | 46400 | nM | 26994844 | |
NPT83 | Cell Line | MCF7 | Homo sapiens | LC50 | = | 30700 | nM | 26994844 |
NPT2 | Others | Unspecified | LC50 | = | 22500 | nM | 26994844 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC71664 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9867 | High Similarity | NPC273033 |
0.9867 | High Similarity | NPC12936 |
0.961 | High Similarity | NPC273758 |
0.9595 | High Similarity | NPC245966 |
0.9467 | High Similarity | NPC285470 |
0.9467 | High Similarity | NPC2785 |
0.9467 | High Similarity | NPC36342 |
0.9342 | High Similarity | NPC151405 |
0.9342 | High Similarity | NPC139901 |
0.9342 | High Similarity | NPC300205 |
0.9221 | High Similarity | NPC164086 |
0.9221 | High Similarity | NPC95868 |
0.9221 | High Similarity | NPC190567 |
0.9136 | High Similarity | NPC69057 |
0.9103 | High Similarity | NPC145053 |
0.9024 | High Similarity | NPC267262 |
0.8916 | High Similarity | NPC418308 |
0.8916 | High Similarity | NPC113307 |
0.8875 | High Similarity | NPC215008 |
0.8861 | High Similarity | NPC73978 |
0.8831 | High Similarity | NPC9796 |
0.881 | High Similarity | NPC19256 |
0.881 | High Similarity | NPC277277 |
0.88 | High Similarity | NPC285679 |
0.8675 | High Similarity | NPC43945 |
0.8667 | High Similarity | NPC74458 |
0.8642 | High Similarity | NPC324624 |
0.8608 | High Similarity | NPC272260 |
0.859 | High Similarity | NPC179726 |
0.8571 | High Similarity | NPC157778 |
0.8554 | High Similarity | NPC307 |
0.8554 | High Similarity | NPC160339 |
0.8506 | High Similarity | NPC289883 |
0.8471 | Intermediate Similarity | NPC325709 |
0.8462 | Intermediate Similarity | NPC78500 |
0.8434 | Intermediate Similarity | NPC123476 |
0.8415 | Intermediate Similarity | NPC197581 |
0.8415 | Intermediate Similarity | NPC39600 |
0.8409 | Intermediate Similarity | NPC472880 |
0.84 | Intermediate Similarity | NPC98880 |
0.8395 | Intermediate Similarity | NPC100039 |
0.8391 | Intermediate Similarity | NPC59677 |
0.8372 | Intermediate Similarity | NPC173413 |
0.8289 | Intermediate Similarity | NPC95289 |
0.8276 | Intermediate Similarity | NPC284475 |
0.8276 | Intermediate Similarity | NPC103346 |
0.8276 | Intermediate Similarity | NPC133461 |
0.8272 | Intermediate Similarity | NPC285716 |
0.8272 | Intermediate Similarity | NPC17408 |
0.8272 | Intermediate Similarity | NPC477703 |
0.8267 | Intermediate Similarity | NPC311343 |
0.825 | Intermediate Similarity | NPC137847 |
0.825 | Intermediate Similarity | NPC76455 |
0.8214 | Intermediate Similarity | NPC252067 |
0.8205 | Intermediate Similarity | NPC208075 |
0.8182 | Intermediate Similarity | NPC188844 |
0.8182 | Intermediate Similarity | NPC1682 |
0.8182 | Intermediate Similarity | NPC153885 |
0.8182 | Intermediate Similarity | NPC155232 |
0.8182 | Intermediate Similarity | NPC323420 |
0.814 | Intermediate Similarity | NPC473345 |
0.8132 | Intermediate Similarity | NPC49994 |
0.8125 | Intermediate Similarity | NPC329318 |
0.8111 | Intermediate Similarity | NPC185208 |
0.8111 | Intermediate Similarity | NPC219573 |
0.809 | Intermediate Similarity | NPC238219 |
0.8077 | Intermediate Similarity | NPC271437 |
0.8025 | Intermediate Similarity | NPC103488 |
0.8022 | Intermediate Similarity | NPC239185 |
0.8 | Intermediate Similarity | NPC260233 |
0.7976 | Intermediate Similarity | NPC149263 |
0.7957 | Intermediate Similarity | NPC472879 |
0.7935 | Intermediate Similarity | NPC134882 |
0.7931 | Intermediate Similarity | NPC153308 |
0.7912 | Intermediate Similarity | NPC12695 |
0.7889 | Intermediate Similarity | NPC34243 |
0.7889 | Intermediate Similarity | NPC246757 |
0.7889 | Intermediate Similarity | NPC261181 |
0.7889 | Intermediate Similarity | NPC291070 |
0.7865 | Intermediate Similarity | NPC110704 |
0.7826 | Intermediate Similarity | NPC240042 |
0.7826 | Intermediate Similarity | NPC265220 |
0.7789 | Intermediate Similarity | NPC329556 |
0.7766 | Intermediate Similarity | NPC109514 |
0.7766 | Intermediate Similarity | NPC476993 |
0.7753 | Intermediate Similarity | NPC110420 |
0.7753 | Intermediate Similarity | NPC303967 |
0.7753 | Intermediate Similarity | NPC58872 |
0.7753 | Intermediate Similarity | NPC67585 |
0.7742 | Intermediate Similarity | NPC75724 |
0.7727 | Intermediate Similarity | NPC477693 |
0.7727 | Intermediate Similarity | NPC477704 |
0.7722 | Intermediate Similarity | NPC326200 |
0.7708 | Intermediate Similarity | NPC249067 |
0.7701 | Intermediate Similarity | NPC164526 |
0.7692 | Intermediate Similarity | NPC16190 |
0.7692 | Intermediate Similarity | NPC169222 |
0.7692 | Intermediate Similarity | NPC235059 |
0.7683 | Intermediate Similarity | NPC298023 |
0.7667 | Intermediate Similarity | NPC476484 |
0.764 | Intermediate Similarity | NPC231591 |
0.7634 | Intermediate Similarity | NPC156021 |
0.7634 | Intermediate Similarity | NPC103048 |
0.7634 | Intermediate Similarity | NPC289201 |
0.7629 | Intermediate Similarity | NPC167336 |
0.7629 | Intermediate Similarity | NPC134120 |
0.7614 | Intermediate Similarity | NPC194326 |
0.7604 | Intermediate Similarity | NPC471829 |
0.7604 | Intermediate Similarity | NPC472691 |
0.7604 | Intermediate Similarity | NPC475939 |
0.7604 | Intermediate Similarity | NPC474866 |
0.7586 | Intermediate Similarity | NPC95965 |
0.7582 | Intermediate Similarity | NPC77273 |
0.7579 | Intermediate Similarity | NPC42211 |
0.7579 | Intermediate Similarity | NPC112552 |
0.75 | Intermediate Similarity | NPC244427 |
0.75 | Intermediate Similarity | NPC318107 |
0.75 | Intermediate Similarity | NPC222390 |
0.7475 | Intermediate Similarity | NPC141523 |
0.7475 | Intermediate Similarity | NPC203732 |
0.7474 | Intermediate Similarity | NPC118343 |
0.7473 | Intermediate Similarity | NPC187725 |
0.7473 | Intermediate Similarity | NPC141607 |
0.7467 | Intermediate Similarity | NPC246588 |
0.7444 | Intermediate Similarity | NPC298115 |
0.7444 | Intermediate Similarity | NPC9822 |
0.7432 | Intermediate Similarity | NPC36357 |
0.7432 | Intermediate Similarity | NPC114327 |
0.7423 | Intermediate Similarity | NPC247976 |
0.7423 | Intermediate Similarity | NPC274443 |
0.7423 | Intermediate Similarity | NPC255676 |
0.7412 | Intermediate Similarity | NPC157055 |
0.7412 | Intermediate Similarity | NPC127343 |
0.74 | Intermediate Similarity | NPC17525 |
0.7374 | Intermediate Similarity | NPC472699 |
0.7374 | Intermediate Similarity | NPC472700 |
0.7368 | Intermediate Similarity | NPC22786 |
0.7356 | Intermediate Similarity | NPC285773 |
0.7356 | Intermediate Similarity | NPC288903 |
0.7347 | Intermediate Similarity | NPC329282 |
0.732 | Intermediate Similarity | NPC25458 |
0.73 | Intermediate Similarity | NPC472695 |
0.73 | Intermediate Similarity | NPC211439 |
0.73 | Intermediate Similarity | NPC472696 |
0.73 | Intermediate Similarity | NPC472683 |
0.73 | Intermediate Similarity | NPC472701 |
0.7273 | Intermediate Similarity | NPC105899 |
0.7273 | Intermediate Similarity | NPC474910 |
0.7273 | Intermediate Similarity | NPC172483 |
0.7273 | Intermediate Similarity | NPC113670 |
0.7263 | Intermediate Similarity | NPC270654 |
0.7255 | Intermediate Similarity | NPC116842 |
0.7241 | Intermediate Similarity | NPC230068 |
0.7234 | Intermediate Similarity | NPC206764 |
0.7234 | Intermediate Similarity | NPC130398 |
0.7229 | Intermediate Similarity | NPC32203 |
0.7229 | Intermediate Similarity | NPC206800 |
0.7228 | Intermediate Similarity | NPC470252 |
0.72 | Intermediate Similarity | NPC100767 |
0.7191 | Intermediate Similarity | NPC294134 |
0.7188 | Intermediate Similarity | NPC145052 |
0.7188 | Intermediate Similarity | NPC229242 |
0.7188 | Intermediate Similarity | NPC317280 |
0.7188 | Intermediate Similarity | NPC329387 |
0.7184 | Intermediate Similarity | NPC268388 |
0.7184 | Intermediate Similarity | NPC186128 |
0.7179 | Intermediate Similarity | NPC291066 |
0.7174 | Intermediate Similarity | NPC62765 |
0.7172 | Intermediate Similarity | NPC114594 |
0.7162 | Intermediate Similarity | NPC198841 |
0.7159 | Intermediate Similarity | NPC243289 |
0.7159 | Intermediate Similarity | NPC44830 |
0.7159 | Intermediate Similarity | NPC208183 |
0.7143 | Intermediate Similarity | NPC320891 |
0.7143 | Intermediate Similarity | NPC200745 |
0.7143 | Intermediate Similarity | NPC71009 |
0.7129 | Intermediate Similarity | NPC470391 |
0.7126 | Intermediate Similarity | NPC71795 |
0.7113 | Intermediate Similarity | NPC325497 |
0.7113 | Intermediate Similarity | NPC476042 |
0.7113 | Intermediate Similarity | NPC217621 |
0.71 | Intermediate Similarity | NPC269457 |
0.71 | Intermediate Similarity | NPC209632 |
0.7087 | Intermediate Similarity | NPC265513 |
0.7083 | Intermediate Similarity | NPC253423 |
0.7083 | Intermediate Similarity | NPC249912 |
0.7083 | Intermediate Similarity | NPC276775 |
0.7083 | Intermediate Similarity | NPC92754 |
0.7073 | Intermediate Similarity | NPC155429 |
0.7071 | Intermediate Similarity | NPC474365 |
0.7071 | Intermediate Similarity | NPC301943 |
0.7067 | Intermediate Similarity | NPC65873 |
0.7067 | Intermediate Similarity | NPC212114 |
0.7067 | Intermediate Similarity | NPC300345 |
0.7067 | Intermediate Similarity | NPC120441 |
0.7059 | Intermediate Similarity | NPC318327 |
0.7059 | Intermediate Similarity | NPC192577 |
0.7059 | Intermediate Similarity | NPC3672 |
0.7059 | Intermediate Similarity | NPC287790 |
0.7053 | Intermediate Similarity | NPC172925 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC71664 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9867 | High Similarity | NPD942 | Approved |
0.9221 | High Similarity | NPD1507 | Clinical (unspecified phase) |
0.8675 | High Similarity | NPD650 | Approved |
0.8605 | High Similarity | NPD1508 | Approved |
0.8452 | Intermediate Similarity | NPD506 | Clinical (unspecified phase) |
0.8315 | Intermediate Similarity | NPD1843 | Approved |
0.8276 | Intermediate Similarity | NPD7609 | Phase 3 |
0.8182 | Intermediate Similarity | NPD7631 | Approved |
0.8022 | Intermediate Similarity | NPD3495 | Discontinued |
0.7889 | Intermediate Similarity | NPD1202 | Approved |
0.7872 | Intermediate Similarity | NPD1932 | Approved |
0.7789 | Intermediate Similarity | NPD1931 | Clinical (unspecified phase) |
0.7789 | Intermediate Similarity | NPD1929 | Approved |
0.7789 | Intermediate Similarity | NPD1930 | Approved |
0.7708 | Intermediate Similarity | NPD1237 | Approved |
0.7634 | Intermediate Similarity | NPD1100 | Approved |
0.7634 | Intermediate Similarity | NPD1099 | Approved |
0.759 | Intermediate Similarity | NPD227 | Approved |
0.759 | Intermediate Similarity | NPD225 | Approved |
0.75 | Intermediate Similarity | NPD9257 | Approved |
0.75 | Intermediate Similarity | NPD2648 | Phase 3 |
0.75 | Intermediate Similarity | NPD9490 | Approved |
0.75 | Intermediate Similarity | NPD2171 | Approved |
0.75 | Intermediate Similarity | NPD2193 | Phase 2 |
0.75 | Intermediate Similarity | NPD9259 | Approved |
0.7474 | Intermediate Similarity | NPD1238 | Approved |
0.7474 | Intermediate Similarity | NPD2066 | Phase 3 |
0.7419 | Intermediate Similarity | NPD4094 | Approved |
0.74 | Intermediate Similarity | NPD2329 | Discontinued |
0.7356 | Intermediate Similarity | NPD9491 | Approved |
0.7347 | Intermediate Similarity | NPD2577 | Clinical (unspecified phase) |
0.7326 | Intermediate Similarity | NPD226 | Approved |
0.732 | Intermediate Similarity | NPD2196 | Discontinued |
0.7312 | Intermediate Similarity | NPD5122 | Clinical (unspecified phase) |
0.7283 | Intermediate Similarity | NPD1239 | Approved |
0.7273 | Intermediate Similarity | NPD675 | Discontinued |
0.7263 | Intermediate Similarity | NPD4657 | Approved |
0.7263 | Intermediate Similarity | NPD4655 | Approved |
0.7229 | Intermediate Similarity | NPD9716 | Approved |
0.7174 | Intermediate Similarity | NPD9258 | Approved |
0.7174 | Intermediate Similarity | NPD9256 | Approved |
0.7128 | Intermediate Similarity | NPD1563 | Approved |
0.71 | Intermediate Similarity | NPD2192 | Approved |
0.71 | Intermediate Similarity | NPD2197 | Approved |
0.71 | Intermediate Similarity | NPD1677 | Discontinued |
0.7053 | Intermediate Similarity | NPD688 | Clinical (unspecified phase) |
0.7033 | Intermediate Similarity | NPD1087 | Approved |
0.699 | Remote Similarity | NPD664 | Approved |
0.6979 | Remote Similarity | NPD1989 | Approved |
0.697 | Remote Similarity | NPD6024 | Approved |
0.697 | Remote Similarity | NPD6027 | Approved |
0.6966 | Remote Similarity | NPD3971 | Phase 1 |
0.6923 | Remote Similarity | NPD4141 | Clinical (unspecified phase) |
0.6907 | Remote Similarity | NPD1565 | Approved |
0.6907 | Remote Similarity | NPD1564 | Approved |
0.6907 | Remote Similarity | NPD1566 | Phase 3 |
0.69 | Remote Similarity | NPD3357 | Discontinued |
0.6882 | Remote Similarity | NPD800 | Approved |
0.6875 | Remote Similarity | NPD1693 | Approved |
0.6875 | Remote Similarity | NPD9260 | Approved |
0.6857 | Remote Similarity | NPD1609 | Clinical (unspecified phase) |
0.6848 | Remote Similarity | NPD4793 | Discontinued |
0.6832 | Remote Similarity | NPD5909 | Discontinued |
0.6832 | Remote Similarity | NPD164 | Approved |
0.6827 | Remote Similarity | NPD1317 | Discontinued |
0.6809 | Remote Similarity | NPD1090 | Approved |
0.6809 | Remote Similarity | NPD1089 | Approved |
0.6809 | Remote Similarity | NPD1086 | Approved |
0.6804 | Remote Similarity | NPD5206 | Clinical (unspecified phase) |
0.68 | Remote Similarity | NPD813 | Approved |
0.6768 | Remote Similarity | NPD7798 | Approved |
0.6737 | Remote Similarity | NPD1007 | Discontinued |
0.6731 | Remote Similarity | NPD6831 | Clinical (unspecified phase) |
0.6702 | Remote Similarity | NPD5346 | Phase 2 |
0.6702 | Remote Similarity | NPD5347 | Phase 2 |
0.6667 | Remote Similarity | NPD1246 | Approved |
0.6667 | Remote Similarity | NPD5951 | Approved |
0.6667 | Remote Similarity | NPD1088 | Approved |
0.6636 | Remote Similarity | NPD7610 | Discontinued |
0.6632 | Remote Similarity | NPD3672 | Approved |
0.6632 | Remote Similarity | NPD3673 | Approved |
0.6607 | Remote Similarity | NPD2345 | Approved |
0.6607 | Remote Similarity | NPD5836 | Discontinued |
0.6604 | Remote Similarity | NPD2181 | Clinical (unspecified phase) |
0.6577 | Remote Similarity | NPD7009 | Phase 2 |
0.6574 | Remote Similarity | NPD1175 | Approved |
0.6571 | Remote Similarity | NPD2182 | Approved |
0.6569 | Remote Similarity | NPD9261 | Approved |
0.6549 | Remote Similarity | NPD4879 | Approved |
0.6543 | Remote Similarity | NPD173 | Clinical (unspecified phase) |
0.6514 | Remote Similarity | NPD1074 | Approved |
0.6514 | Remote Similarity | NPD1075 | Approved |
0.6514 | Remote Similarity | NPD1073 | Approved |
0.65 | Remote Similarity | NPD9495 | Approved |
0.6491 | Remote Similarity | NPD6287 | Discontinued |
0.6491 | Remote Similarity | NPD1547 | Clinical (unspecified phase) |
0.6489 | Remote Similarity | NPD1282 | Approved |
0.646 | Remote Similarity | NPD1727 | Approved |
0.6452 | Remote Similarity | NPD5734 | Clinical (unspecified phase) |
0.6435 | Remote Similarity | NPD4878 | Approved |
0.6435 | Remote Similarity | NPD3972 | Approved |
0.6429 | Remote Similarity | NPD9497 | Clinical (unspecified phase) |
0.6422 | Remote Similarity | NPD1241 | Discontinued |
0.6408 | Remote Similarity | NPD6647 | Phase 2 |
0.6404 | Remote Similarity | NPD7457 | Clinical (unspecified phase) |
0.6396 | Remote Similarity | NPD405 | Clinical (unspecified phase) |
0.6379 | Remote Similarity | NPD5159 | Phase 2 |
0.6379 | Remote Similarity | NPD5157 | Phase 1 |
0.6379 | Remote Similarity | NPD5158 | Clinical (unspecified phase) |
0.6373 | Remote Similarity | NPD3135 | Clinical (unspecified phase) |
0.6372 | Remote Similarity | NPD1245 | Approved |
0.6348 | Remote Similarity | NPD1201 | Approved |
0.6337 | Remote Similarity | NPD466 | Approved |
0.6337 | Remote Similarity | NPD5926 | Approved |
0.633 | Remote Similarity | NPD7094 | Approved |
0.633 | Remote Similarity | NPD6858 | Approved |
0.6325 | Remote Similarity | NPD1876 | Approved |
0.6325 | Remote Similarity | NPD1574 | Approved |
0.6321 | Remote Similarity | NPD9263 | Approved |
0.6321 | Remote Similarity | NPD9265 | Clinical (unspecified phase) |
0.6321 | Remote Similarity | NPD9267 | Approved |
0.6321 | Remote Similarity | NPD9264 | Approved |
0.6316 | Remote Similarity | NPD7163 | Clinical (unspecified phase) |
0.6316 | Remote Similarity | NPD4733 | Approved |
0.6311 | Remote Similarity | NPD4803 | Discontinued |
0.6292 | Remote Similarity | NPD4144 | Approved |
0.6292 | Remote Similarity | NPD4147 | Approved |
0.6286 | Remote Similarity | NPD5048 | Discontinued |
0.6275 | Remote Similarity | NPD742 | Approved |
0.6271 | Remote Similarity | NPD1470 | Approved |
0.6271 | Remote Similarity | NPD1593 | Approved |
0.6262 | Remote Similarity | NPD74 | Approved |
0.6262 | Remote Similarity | NPD9266 | Approved |
0.6261 | Remote Similarity | NPD3836 | Clinical (unspecified phase) |
0.6239 | Remote Similarity | NPD9508 | Approved |
0.6238 | Remote Similarity | NPD9566 | Approved |
0.6218 | Remote Similarity | NPD2798 | Approved |
0.6218 | Remote Similarity | NPD4980 | Approved |
0.6216 | Remote Similarity | NPD690 | Clinical (unspecified phase) |
0.62 | Remote Similarity | NPD6048 | Clinical (unspecified phase) |
0.62 | Remote Similarity | NPD6049 | Phase 2 |
0.6186 | Remote Similarity | NPD6330 | Clinical (unspecified phase) |
0.6182 | Remote Similarity | NPD5277 | Phase 2 |
0.6176 | Remote Similarity | NPD253 | Approved |
0.6174 | Remote Similarity | NPD3412 | Clinical (unspecified phase) |
0.6161 | Remote Similarity | NPD1323 | Discontinued |
0.6161 | Remote Similarity | NPD1025 | Discontinued |
0.6154 | Remote Similarity | NPD1475 | Approved |
0.6154 | Remote Similarity | NPD3356 | Approved |
0.6154 | Remote Similarity | NPD3355 | Approved |
0.6134 | Remote Similarity | NPD1164 | Approved |
0.6132 | Remote Similarity | NPD1018 | Approved |
0.6126 | Remote Similarity | NPD7077 | Approved |
0.6126 | Remote Similarity | NPD7076 | Approved |
0.6121 | Remote Similarity | NPD1889 | Phase 1 |
0.6117 | Remote Similarity | NPD3097 | Clinical (unspecified phase) |
0.6106 | Remote Similarity | NPD9493 | Approved |
0.6092 | Remote Similarity | NPD294 | Approved |
0.6092 | Remote Similarity | NPD292 | Approved |
0.6087 | Remote Similarity | NPD1217 | Clinical (unspecified phase) |
0.6087 | Remote Similarity | NPD4196 | Clinical (unspecified phase) |
0.6087 | Remote Similarity | NPD3981 | Approved |
0.6087 | Remote Similarity | NPD3979 | Approved |
0.6087 | Remote Similarity | NPD3903 | Approved |
0.6087 | Remote Similarity | NPD1617 | Discontinued |
0.6087 | Remote Similarity | NPD3904 | Approved |
0.6071 | Remote Similarity | NPD1021 | Approved |
0.6071 | Remote Similarity | NPD1020 | Approved |
0.6071 | Remote Similarity | NPD2319 | Discontinued |
0.6071 | Remote Similarity | NPD1023 | Approved |
0.6071 | Remote Similarity | NPD1022 | Approved |
0.6071 | Remote Similarity | NPD851 | Approved |
0.6071 | Remote Similarity | NPD853 | Approved |
0.6066 | Remote Similarity | NPD6039 | Approved |
0.6058 | Remote Similarity | NPD5630 | Phase 1 |
0.6055 | Remote Similarity | NPD3646 | Clinical (unspecified phase) |
0.6055 | Remote Similarity | NPD2067 | Discontinued |
0.6053 | Remote Similarity | NPD2347 | Approved |
0.6053 | Remote Similarity | NPD997 | Clinical (unspecified phase) |
0.605 | Remote Similarity | NPD2056 | Discontinued |
0.605 | Remote Similarity | NPD1482 | Clinical (unspecified phase) |
0.6047 | Remote Similarity | NPD1673 | Approved |
0.6023 | Remote Similarity | NPD9728 | Phase 1 |
0.6022 | Remote Similarity | NPD3035 | Approved |
0.6022 | Remote Similarity | NPD4026 | Approved |
0.6022 | Remote Similarity | NPD4027 | Approved |
0.602 | Remote Similarity | NPD1629 | Approved |
0.602 | Remote Similarity | NPD689 | Discontinued |
0.602 | Remote Similarity | NPD1628 | Approved |
0.6017 | Remote Similarity | NPD1077 | Clinical (unspecified phase) |
0.6016 | Remote Similarity | NPD2313 | Discontinued |
0.6016 | Remote Similarity | NPD5422 | Clinical (unspecified phase) |
0.6 | Remote Similarity | NPD1203 | Approved |
0.6 | Remote Similarity | NPD9545 | Approved |
0.6 | Remote Similarity | NPD5653 | Discontinued |
0.6 | Remote Similarity | NPD6588 | Clinical (unspecified phase) |
0.5984 | Remote Similarity | NPD6832 | Phase 2 |
0.5981 | Remote Similarity | NPD1766 | Approved |
0.5981 | Remote Similarity | NPD1761 | Approved |
0.5981 | Remote Similarity | NPD1767 | Approved |
PubChem CID   | 637760 |
ChEMBL   | CHEMBL7976 |
ZINC   |
Molecular Weight:   | 208.09 |
ALogP:   | 0.0973 |
MLogP:   | 3 |
XLogP:   | 6.912 |
# Rotatable Bonds:   | 3 |
Polar Surface Area:   | 17.07 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 0 |
# Rings:   | 2 |
# Heavy Atoms:   | 16 |